Article
Short communication: intermediate prevalence of HIV type 1 primary antiretroviral resistance in Ceará State, Northeast Brazil.
AIDS research and human retroviruses - 1 Feb 2011
Arruda Erico, Simões Leda, Sucupira Cecília, Medeiros Melissa, Arruda Eurico, Diaz Ricardo S, Lima Aldo
Abstract excerpt
Brazil is a large developing country where almost all FDA-licensed antiretrovirals are made available to more than 200,000 individuals under antiretroviral treatment. General primary HIV-1 resistance in Brazil is assumed to be low, but data are scarce, especially in the Northeast region. To evalu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
